p53 codon 72 polymorphism in Taiwanese breast cancer patients

There are clear discrepancies between ethnicity and geographic area regarding the peak age incidence and mortality of breast cancer. Underlying variances include genetic, environmental, and socioeconomic factors. The wild-type p53 codon has two common polymorphic variants from a single-base-pair sub...

Full description

Bibliographic Details
Main Authors: Fang-Ming Chen, Fu Ou-Yang, Sheau-Fang Yang, Eing-Mei Tsai, Ming-Feng Hou
Format: Article
Language:English
Published: Wiley 2013-05-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1607551X12002598
_version_ 1830518245017255936
author Fang-Ming Chen
Fu Ou-Yang
Sheau-Fang Yang
Eing-Mei Tsai
Ming-Feng Hou
author_facet Fang-Ming Chen
Fu Ou-Yang
Sheau-Fang Yang
Eing-Mei Tsai
Ming-Feng Hou
author_sort Fang-Ming Chen
collection DOAJ
description There are clear discrepancies between ethnicity and geographic area regarding the peak age incidence and mortality of breast cancer. Underlying variances include genetic, environmental, and socioeconomic factors. The wild-type p53 codon has two common polymorphic variants from a single-base-pair substitution at codon 72, where either C-C-C encodes proline (p53-p72) or C-G-C encodes arginine (p53-R72). We aim to study the p53 codon 72 genotypes of patients with breast cancer in Taiwan and make a comparison with the published data to ascertain whether any difference exists between Taiwanese and Western patients with breast cancer. We also evaluated the effect of the p53 codon 72 polymorphism on clinicopathologic features. We examined blood from 170 Taiwanese women with breast cancer with polymerase chain reaction–restriction fragment length polymorphism for the genotypes of p53 codon 72. For the p53 codon 72 polymorphism, there were 31 p53-P/P72 (18.2%), 93 p53-R/P72 (54.7%), and 46 p53-R/R72 (27.1%) with the allele frequencies 0.54 for the p53-R72 and 0.46 for p53-P72, respectively. Our results indicate that there was more p53-P72 (40.6% in Asians vs. 26.4% in Caucasians) and twice the incidence of p53-P/P72 homozygotes (18% in Asians vs. 8% in Caucasians) among the Asian population. Patients with the p53-R/R72 variant were more likely to have a t1 tumor size status (55.2%) compared with patients with the P53-P/R72 (30.9%) or P53-P/P72 variant (36%). Our results support the hypothesis that genetic factors may contribute to the difference between Taiwanese or Asian breast cancer and Western breast cancer patient populations.
first_indexed 2024-12-22T04:16:24Z
format Article
id doaj.art-c406d85715f44455927f56e7cd4712b8
institution Directory Open Access Journal
issn 1607-551X
language English
last_indexed 2024-12-22T04:16:24Z
publishDate 2013-05-01
publisher Wiley
record_format Article
series Kaohsiung Journal of Medical Sciences
spelling doaj.art-c406d85715f44455927f56e7cd4712b82022-12-21T18:39:24ZengWileyKaohsiung Journal of Medical Sciences1607-551X2013-05-0129525926410.1016/j.kjms.2012.09.004p53 codon 72 polymorphism in Taiwanese breast cancer patientsFang-Ming Chen0Fu Ou-Yang1Sheau-Fang Yang2Eing-Mei Tsai3Ming-Feng Hou4Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanGraduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Pathology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, TaiwanGraduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDivision of Gastrointestinal and General Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, TaiwanThere are clear discrepancies between ethnicity and geographic area regarding the peak age incidence and mortality of breast cancer. Underlying variances include genetic, environmental, and socioeconomic factors. The wild-type p53 codon has two common polymorphic variants from a single-base-pair substitution at codon 72, where either C-C-C encodes proline (p53-p72) or C-G-C encodes arginine (p53-R72). We aim to study the p53 codon 72 genotypes of patients with breast cancer in Taiwan and make a comparison with the published data to ascertain whether any difference exists between Taiwanese and Western patients with breast cancer. We also evaluated the effect of the p53 codon 72 polymorphism on clinicopathologic features. We examined blood from 170 Taiwanese women with breast cancer with polymerase chain reaction–restriction fragment length polymorphism for the genotypes of p53 codon 72. For the p53 codon 72 polymorphism, there were 31 p53-P/P72 (18.2%), 93 p53-R/P72 (54.7%), and 46 p53-R/R72 (27.1%) with the allele frequencies 0.54 for the p53-R72 and 0.46 for p53-P72, respectively. Our results indicate that there was more p53-P72 (40.6% in Asians vs. 26.4% in Caucasians) and twice the incidence of p53-P/P72 homozygotes (18% in Asians vs. 8% in Caucasians) among the Asian population. Patients with the p53-R/R72 variant were more likely to have a t1 tumor size status (55.2%) compared with patients with the P53-P/R72 (30.9%) or P53-P/P72 variant (36%). Our results support the hypothesis that genetic factors may contribute to the difference between Taiwanese or Asian breast cancer and Western breast cancer patient populations.http://www.sciencedirect.com/science/article/pii/S1607551X12002598p53Single nucleotide polymorphism
spellingShingle Fang-Ming Chen
Fu Ou-Yang
Sheau-Fang Yang
Eing-Mei Tsai
Ming-Feng Hou
p53 codon 72 polymorphism in Taiwanese breast cancer patients
Kaohsiung Journal of Medical Sciences
p53
Single nucleotide polymorphism
title p53 codon 72 polymorphism in Taiwanese breast cancer patients
title_full p53 codon 72 polymorphism in Taiwanese breast cancer patients
title_fullStr p53 codon 72 polymorphism in Taiwanese breast cancer patients
title_full_unstemmed p53 codon 72 polymorphism in Taiwanese breast cancer patients
title_short p53 codon 72 polymorphism in Taiwanese breast cancer patients
title_sort p53 codon 72 polymorphism in taiwanese breast cancer patients
topic p53
Single nucleotide polymorphism
url http://www.sciencedirect.com/science/article/pii/S1607551X12002598
work_keys_str_mv AT fangmingchen p53codon72polymorphismintaiwanesebreastcancerpatients
AT fuouyang p53codon72polymorphismintaiwanesebreastcancerpatients
AT sheaufangyang p53codon72polymorphismintaiwanesebreastcancerpatients
AT eingmeitsai p53codon72polymorphismintaiwanesebreastcancerpatients
AT mingfenghou p53codon72polymorphismintaiwanesebreastcancerpatients